At InjectCo, eligibility is determined by a licensed provider based on factors such as body mass index, weight-related health considerations, and overall medical history
Zepbound is FDA-approved for chronic weight management (obesity/overweight with comorbidities) and obstructive sleep apnea
Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists
Studies have demonstrated that GHK-Cu can tighten loose skin, enhance skin density, and reduce hyperpigmentation 2
The administration is non-invasive and requires no injections, medical devices, or surgical tools
The median duration on the second GLP-1RA therapy before switching to a third therapy was highest for tirzepatide (5%) at 10.3 months, followed by dulaglutide (32.5%) at 9.4, semaglutide (28%) at 6, liraglutide (32.5%) at 5.6, and exenatide (2%) at 2 months